Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
The Lancet
2019
393
10167
156-167
Bispecific T-Cell Engager-Armored Chimeric Antigen Receptor T Cells Overcome Antigen Escape From EGFRvIII-Targeted Therapy For Glioblastoma
Neurosurgery
2019
66 Suppl 1
45-45
Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays.
Adv Sci (Weinh)
2019
6
23
Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.
Blood Adv
2019
3
21
3248-3260
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity.
Nat Biotechnol
2019
37
9
1049-1058
Loss of the fanconi anemia-associated protein NIPA causes bone marrow failure
Oncology Research and Treatment
2019
42 Suppl 4
151-151
The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2
Blood
2019
134 Suppl 1
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
J Immunother Cancer
2019
7
1
Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19.
Clin Cancer Res
2019
25
23
7046-7057
Characterization and transfer of extracellular vesicles (EVs) within the bone marrow niche in acute myeloid leukemia (AML)
Oncology Research and Treatment
2019
42 Suppl 4
310-310